Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1464-1472

  Wang, Degui ^a,d   Huang, H J Su ^a,b   Kazlauskas, Andrius ^c   Cavenee, Webster K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL SPECIFICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLIOMA CELL; MEDIATOR RELEASE; MITOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TARGET CELL; WOUND HEALING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; LYMPHOKINES; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033119572     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Klagsbrun, M., and D'Amore, P. A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev., 7: 259-270, 1996.
2. Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem., 271: 603-606, 1996.
3. Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Exper. Suppl., 79: 233-269, 1997.
4. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
5. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell. 3: 211-220, 1992.
6. Breier, G., Albrecht, U., Sterrer, S., and Risau, W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development (Camb.), 114: 521-532, 1992.
7. Millauer, B., Wizigmann, V. S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
8. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., Nguyen, H. V., Aiello, L. M., Ferrara, N., and King, G. L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders [see comments]. N. Engl. J. Med., 331: 1480-1487, 1994.
9. Dumont, D. J., Fong, G. H., Puri, M. C., Gradwohl, G., Alitalo, K., and Breitman, M. L. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn., 203: 80-92, 1995.
10. Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., and Smith, L. E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA, 92: 905-909, 1995.
11. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (Lond.), 376: 62-66, 1995.
12. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (Lond.), 376: 66-70, 1995.
13. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 380: 439-442, 1996.
14. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
15. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
16. Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
17. Li, J., Perrella, M. A., Tsai, J. C., Yet, S. F., Hsieh, C. M., Yoshizumi, M., Patterson, C., Endege, W. O., Zhou, F., and Lee, M. E. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem., 270, 308-312, 1995.
18. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
19. Finkenzeller, G., Marme, D., Weich, H. A., and Hug, H. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res., 52; 4821-4823, 1992.
20. Brogi, E., Wu, T., Namiki, A., and Isner, J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation, 90; 649-652, 1994.
21. Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
22. Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., and Dvorak, H. F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med., 180: 1141-1146, 1994.
23. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Werner, S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem., 270: 12607-12613, 1995.
24. Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., and Levi, B. Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271: 736-741, 1996.
25. Kieser, A., Weich, H. A., Brandner, G., Marme, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9: 963-969, 1994.
26. Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., and Marme, D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res., 56, 2299-2301, 1996.
27. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
28. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
29. Mukhopadhyay, D., Tsiokas, L., Zhou, X. M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
30. Plate, K. H., Breier, G., Farrell, C. L., and Risau, W. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest., 67: 529-534, 1992.
31. Hermanson, M., Funa, K., Hartman, M., Claesson-Welsh, L., Heldin, C. H., Westermark, B., and Nister, M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res., 52: 3213-3219, 1992.
32. Reuterdahl, C., Sundberg, C., Rubin, K., Funa, K., and Gerdin, B. Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J. Clin. Invest., 91: 2065-2075, 1993.
33. Moulin, V. Growth factors in skin wound healing. Eur. J. Cell Biol., 68: 1-7, 1995.
34. Kazlauskas, A. Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev., 4: 5-14, 1994.
35. Claesson-Welsh, L. Signal transduction by the PDGF receptors. Prog. Growth Factor Res., 5: 37-54, 1994.
36. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269: 26988-26995, 1994.
37. Valius, M., and Kazlauskas, A. Phospholipase C-γl, and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell, 73: 321-334, 1993.
38. Dhand, R., Hara, K., Hiles, I., Bax, B., Gout, I., Panayotou, G., Fry, M. J., Yonezawa, K., Kasuga, M., and Waterfield, M. D. PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J., 13: 511-521, 1994.
39. Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., and Downward, J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell, 89: 457-467, 1997.
40. Kazlauskas, A., and Cooper, J. A. Protein kinase C mediates platelet-derived growth factor-induced tyrosine phosphorylation of p42. J. Cell Biol., 106: 1395-1402, 1988.
41. Stack, J. H., Herman, P. K., Schu, P. V., and Emr, S. D. A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J., 12: 2195-2204, 1993.
42. Walsh, J. P., Caldwell, K. K., and Majerus, P. W. Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc. Natl. Acad. Sci. USA, 88: 9184-9187, 1991.
43. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271: 2746-2753, 1996.
44. Toker, A., and Cantley, L. C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature (Lond.), 387: 673-676, 1997.
45. Klinghoffer, R. A., Duckworth, B., Valius, M., Cantley, L., and Kazlauskas, A. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated hy receptor binding of SH2-domain-containing proteins which influence Ras activity. Mol. Cell. Biol., 16: 5905-5914, 1996.
46. Hermansson, M., Nister, M., Betsholtz, C., Heldin, C. H., Westermark, B., and Funa, K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc. Natl. Acad. Sci. USA, 85: 7748-7752, 1988.
47. Funa, K., Papanicolaou, V., Juhlin, C., Rastad, J., Akerstrom, G., Heldin, C. H., and Oberg, K. Expression of platelet-derived growth factor β-receptors on stromal tissue cells in human carcinoid tumors. Cancer Res., 50: 748-753, 1990.
48. Reuterdahl, C., Tingstrom, A., Terracio, L., Funa, K., Heldin, C. H., and Rubin, K. Characterization of platelet-derived growth factor β-receptor expressing cells in the vasculature of human rheumatoid synovium. Lab. Invest., 64: 321-329, 1991.
49. Battegay, E. J., Rupp, J., Iruela-Arispe, L., Sage, E. H., and Pech, M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF β-receptors. J. Cell Biol., 125: 917-928, 1994.
50. Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M., and Westermark, B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl. Acad. Sci. USA. 90: 393-397, 1993.
51. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86: 353-64, 1996.
52. Ladoux, A., and Frelin, C. Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels. Biochem. Biophys. Res. Commun., 194: 799-803, 1993.
53. Uchida, K., Uchida, S., Nitta, K., Yumura, W., Marumo, F., and Nihei, H. Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. Am. J. Physiol., 266: F81-F88, 1994.
54. Simorre-Pinatel, V., Guerrin, M., Chollet, P., Penary, M., Clamens, S., Malecaze, F., and Plouet, J. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest. Ophthalmol. Vis. Sci., 35: 3393-3400, 1994.
55. Malecaze, F., Clamens, S., Simorre-Pinatel, V., Mathis, A., Chollet, P., Favard, C., Bayard, F., and Plouet, J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch. Ophthalmol., 112: 1476-1482, 1994.
56. Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., and Isner, J. M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem., 270, 31189-31195, 1995.
57. Nomura, M., Yamagishi, S., Harada, S., Hayashi, Y., Yamashima, T., Yamashita, J., and Yamamoto, H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem., 270: 28316-28324, 1995.
58. Mazure, N. M. Chen, E. Y., Laderoute, K. R., and Giaccia, A. J. Induction of vascular endothelial growth factor hy hypoxia is modulated by a phosphatidylinositol 3-kinase/ Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood. 90: 3322-3331, 1997.
59. Chang, H. W., Aoki, M., Fruman, D., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., and Vogt, P. K. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (Washington DC), 276: 1848-1850, 1997.
60. Derman, M. P., Toker, A., Hartwig, J. H., Spokes, K. Falck, J. R., Chen, C. S., Cantley, L. C., and Cantley, L. G. The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C. J. Biol. Chem., 272: 6465-6470, 1997.
61. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997.
62. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H., and Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16: 2783-2793, 1997.
63. Shaw, L. M. R., Rabinovitz, I., Wang, H. H-F., Tpker, A., and Mercurio, A. M. Activation of phosphainositide 3-OH kinase by the a6b4 integrin promotes carcinoma invasion. Cell. 91: 949-960, 1997.
64. Carpenter, C. L., and Cantley, L. C. Phosphoinositide kinases. Curr. Opin. Cell Biol., 8: 153-158, 1996.
65. Tansey, M. G., Chu, G. C., and Merlie, J. P. ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidy-linositol 3-kinase and Ras/MAPK pathway. J. Cell Biol., 134: 465-476, 1996.